TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from SinoMab Bioscience Ltd. ( (HK:3681) ).
SinoMab BioScience Limited has adopted new terms of reference for its Nomination Committee, which will be composed of at least three members, primarily independent non-executive directors, with a focus on diversity. This move is in compliance with the listing requirements of the Hong Kong Stock Exchange and aims to enhance the company’s governance structure, potentially impacting its operational efficiency and stakeholder confidence.
More about SinoMab Bioscience Ltd.
SinoMab BioScience Limited is a biotechnology company based in Hong Kong, focusing on the development of therapeutic antibodies for the treatment of various diseases. The company is committed to advancing its pipeline of innovative products to address unmet medical needs.
Average Trading Volume: 9,430,161
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.28B
See more data about 3681 stock on TipRanks’ Stock Analysis page.